Midi Utama Indonesia Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Midi Utama Indonesia Tbk. trades at Rp270 (market cap 9.23T, 3.83M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Midi Utama Indonesia Tbk. is far larger — about 19.6× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 3.83M). Which is the better fit depends on your goals.
| MIDI | PRDL | |
|---|---|---|
Market Cap | 9.23T | 470.58B |
Volume | 3.83M | 28.43M |
Lot | 38.27K | 284.34K |
Turnover | 1.04B | 7.8B |
Average Price | 271.89 | 274.19 |
Value | 1.04B | 7.8B |
Indicative Equilibrium Price | 270 | 270 |
Indicative Equilibrium Volume | 188 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Read more on MIDI →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →